Frontiers in Immunology (Feb 2024)

Aberrant NK cell profile in gestational diabetes mellitus with fetal growth restriction

  • Yujing Xiong,
  • Yujing Xiong,
  • Yazhen Wang,
  • Mengqi Wu,
  • Shuqiang Chen,
  • Hui Lei,
  • Hui Mu,
  • Haikun Yu,
  • Yongli Hou,
  • Kang Tang,
  • Xutao Chen,
  • Jie Dong,
  • Xiaohong Wang,
  • Lihua Chen

DOI
https://doi.org/10.3389/fimmu.2024.1346231
Journal volume & issue
Vol. 15

Abstract

Read online

Gestational diabetes mellitus (GDM) is a gestational disorder characterized by hyperglycemia, that can lead to dysfunction of diverse cells in the body, especially the immune cells. It has been reported that immune cells, specifically natural killer (NK) cells, play a crucial role in normal pregnancy. However, it remains unknown how hyperglycemia affects NK cell dysfunction thus participates in the development of GDM. In this experiment, GDM mice were induced by an intraperitoneal injection of streptozotocin (STZ) after pregnancy and it has been found that the intrauterine growth restriction occurred in mice with STZ-induced GDM, accompanied by the changed proportion and function of NK cells. The percentage of cytotoxic CD27-CD11b+ NK cells was significantly increased, while the proportion of nourished CD27-CD11b- NK cells was significantly reduced in the decidua of GDM mice. Likewise, the same trend appeared in the peripheral blood NK cell subsets of GDM patients. What’s more, after intrauterine reinfusion of NK cells to GDM mice, the fetal growth restriction was alleviated and the proportion of NK cells was restored. Our findings provide a theoretical and experimental basis for further exploring the pathogenesis of GDM.

Keywords